[HTML][HTML] A Decade of Progress in Gene Targeted Therapeutic Strategies in Duchenne Muscular Dystrophy: A Systematic Review

L Chung Liang, N Sulaiman, MD Yazid - Frontiers in Bioengineering …, 2022 - frontiersin.org
As one of the most severe forms of muscle dystrophy, Duchenne muscular dystrophy (DMD)
results in progressive muscle wasting, ultimately resulting in premature death due to …

Morpholino oligonucleotide-mediated exon skipping for DMD treatment: Past insights, present challenges and future perspectives

S Gupta, SN Sharma, J Kundu, S Pattanayak… - Journal of …, 2023 - Springer
Duchenne muscular dystrophy (DMD) is an X-linked genetic disease primarily affecting boys
causing loss of the dystrophin protein, ultimately leading to muscle wastage and death by …

[HTML][HTML] Detailed genetic and functional analysis of the hDMDdel52/mdx mouse model

A Yavas, R Weij, M van Putten, E Kourkouta… - PLoS …, 2020 - journals.plos.org
Duchenne muscular dystrophy (DMD) is a severe, progressive neuromuscular disorder
caused by reading frame disrupting mutations in the DMD gene leading to absence of …

[HTML][HTML] Retinal dystrophins and the retinopathy of Duchenne muscular dystrophy

MTS Barboni, A Joachimsthaler, MJ Roux… - Progress in Retinal and …, 2023 - Elsevier
Duchenne muscular dystrophy (DMD) is caused by X-linked inherited or de novo DMD gene
mutations predominantly affecting males who develop early-onset muscle degeneration …

Oligonucleotide therapeutics and their chemical modification strategies for clinical applications

H Kim, S Kim, D Lee, D Lee, J Yoon, H Lee - Journal of Pharmaceutical …, 2024 - Springer
Background Oligonucleotide therapeutics have emerged as a promising and dynamic class
of pharmaceutical agents with remarkable potential for treating a wide spectrum of genetic …

Patent landscape of molecular and cellular targeted therapies for recessive dystrophic epidermolysis bullosa

M Dourado Alcorte, MC Sogayar… - Expert opinion on …, 2019 - Taylor & Francis
ABSTRACT Introduction: Recessive Dystrophic Epidermolysis Bullosa (RDEB) is a
monogenetic inherited genodermatosis associated with deleterious mutations in the gene …

[HTML][HTML] Restoration of normal NF1 function with antisense morpholino treatment of recurrent pathogenic patient-specific variant c. 1466A> G; p. Y489C

EK Awad, M Moore, H Liu, L Ciszewski… - Journal of Personalized …, 2021 - mdpi.com
Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic disorder with almost 3000
different disease-causing variants within the NF1 gene identified. Up to 44% of these …

From Drug Prescription to Gene-Based Therapies

A proposed by Lee - Progress on musculoskeletal disorders …, 2023 - books.google.com
Conventionally, the gold standard of DMD drug therapy is the administration of
glucocorticoid steroids, either prednisone or deflazacort, that are routinely prescribed to …

Systematic Mining of Gene Co-Expression Network Suggesting a New Drug Repositioning for the Effective Treatment of Duchenne Muscular Dystrophy: Drug …

A Derakhshani, M Moosavi, S Nasseri… - Iranian Journal of …, 2021 - theses.sbmu.ac.ir
Abstract Duchenne Muscular Dystrophy (DMD) is one of the most common inherited
disorders worldwide. As there is currently no absolute treatment, the present systems …

[PDF][PDF] Detailed genetic and functional analysis of the hDMDdel52/mdx mouse model

R Weij, M van Putten, E Kourkouta, C Beekman… - 2020 - scholarlypublications …
Duchenne muscular dystrophy (DMD) is a severe, progressive neuromuscular disorder
caused by reading frame disrupting mutations in the DMD gene leading to absence of …